A new research article resulting from a collaboration between the Institut de Cancérologie de Lorraine, bladder cancer company Photocure and ETAP-Lab was recently published in the journal Biomedicines: “Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer” >> Article This article reports on the effectiveness of a new therapy for the treatment of bladder cancer. By means of longitudinal follow-up over a period of up

The poster we presented at the Alzheimer’s Disease and Parkinson’s Disease conference is now available ; it’s all about our innovative in vitro and in vivo models of Alzheimer’s disease, which are based on the use of human A-Beta 1-42 oligomers. The poster focuses on the main results of the characterisation of the model in the aged mouse. This reproducible and translational model is a new tool for the evaluation of compounds targeting the early stages of Alzheimer’s disease. We are very

Dr. Ahmad Allouche (Head of In Vitro Biology at ETAP-Lab) is co-author of the article: “Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease” published in the journal Glia. Conducted in collaboration with Dr. @Manuel Buttini from Luxembourg (National Center of Pathology), this work shows that, in the early induction stages of the Parkinson's disease process, diffusible alpha-synuclein oligomers spreeding is responsible for neurodegeneration and neuroinflammation. This induces microglia activation, prior to

ETAP-Lab est à la recherche d’un(e) « PROSPECTEUR(TRICE) COMMERCIAL(E)». Pour accompagner sa croissance à l’international, ETAP-Lab recrute. Vous aimez les challenges ?  Participez au développement commercial de notre entreprise ! Pré-requis : Bac+2/+3, avec une double compétence en biologie. Type de contrat : CDD de 6 mois avec évolution possible vers un CDI Localisation : Nancy (54)

7 déc – ETAP-Lab, représenté par Nicolas Violle (PDG), participera à l’événement 360 Grand Est : rendez-vous incontournable de l’innovation et de la croissance en Région Grand Est. Entre conférences, master class et tables rondes, relevons ensemble le défi de l’innovation en Santé !  Profitons de cette occasion pour échanger autour de vos projets précliniques en Neurologie et Dermatologie. Et si nous prenions rendez-vous ?

Discover ETAP-Lab and other biotech businesses at an Afterwork evening on November 18th, organised by Biovalley France. Nicolas Violle will be delighted to meet you and tell you about what we do at ETAP-Lab. A rare opportunity to connect with key players in the Lorraine region. Thanks to BioValley France for making it happen!

Hypo-excitability was reported in the peri-infarct tissue following stroke, an effect counteracted by a blockage of α5-GABAA receptors in adult rodents. Our present study aims to evaluate the effect of a selective α5-GABAA receptor antagonist, S 44819, in stroke in juvenile animals. We have set up and characterized an original model of transient ischemic stroke in 28 day-old Sprague-Dawley rats (45-min occlusion of the middle cerebral artery by intraluminal suture). In this model, S 44819 (1, 3 and 10 mg/kg,

Invisible but devastating, diabetes is a chronic disease affecting more than 463 million adults worldwide; it results in more than 1.5 million deaths each year. The number of patients is expected to reach 700 million by 2045 - so treating diabetes and its complications really is a major health challenge! On this day of solidarity and awareness, ETAP-Lab would like to show its support for diabetic patients. At ETAP-Lab, we’re already involved in fighting back against diabetes — our work on developing

Renewal of ETAP-Lab’s ISO 9001 certification (v2015)! A well-managed quality system is key to a high performance, trustworthy preclinical service. ETAP-Lab has been investing in quality management continuously for almost 10 years now. And for 10 years, ISO 9001 certification has recognized the excellence of our quality management system in the areas of consultancy and expertise as well as in the conduct of in vitro and in vivo preclinical research studies. Because we are always scrupulous in carrying out and monitoring our